image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Plus500

March 2025

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • PLUS
  • Price:
  • 2850p
The shares spiked to a new high of almost £29 after Plus500 guided to revenues well ahead of expectations and expected to be US$768m (Panmure Liberum forecast: US$720m) with EBITDA in line. This came thanks to strong customer acquisition activity in Q4 delivering the most new additions since Q2 21 at 36,000 (+45% on Q3). The lack of a “beat” to EBITDA is simply a reflection of that reinvestment in customer acquisition. Net cash is expected to be US$900m, despite US$361m shareholder returns last year. Although Panmure has left EBITDA forecasts unchanged, it notes the already positive outlook has been boosted by securing additional clearing membership permits at ICE Clear in the huge US market alongside a license from the Sec ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe